vs
Side-by-side financial comparison of 60 DEGREES PHARMACEUTICALS, INC. (SXTP) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.
60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $182.5K, roughly 1.7× TREASURE GLOBAL INC). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -1169.1%, a 694.9% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -12.0%). 60 DEGREES PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-1.8M vs $-2.4M). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -83.5%).
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
SXTP vs TGL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $303.4K | $182.5K |
| Net Profit | $-1.4M | $-2.1M |
| Gross Margin | 60.2% | 0.7% |
| Operating Margin | -632.0% | -953.5% |
| Net Margin | -474.2% | -1169.1% |
| Revenue YoY | 25.6% | -12.0% |
| Net Profit YoY | 29.7% | -124.5% |
| EPS (diluted) | $-8.26 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $303.4K | — | ||
| Q3 25 | $437.6K | $182.5K | ||
| Q2 25 | $100.9K | $1.2M | ||
| Q1 25 | $163.6K | $666.5K | ||
| Q4 24 | $241.6K | $301.9K | ||
| Q3 24 | $135.3K | $207.4K | ||
| Q2 24 | $125.0K | $293.0K | ||
| Q1 24 | $105.7K | $1.6M |
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $-2.3M | $-2.1M | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-1.9M | $1.3M | ||
| Q4 24 | $-2.0M | $-232.3K | ||
| Q3 24 | $-2.2M | $-950.7K | ||
| Q2 24 | $-4.2M | — | ||
| Q1 24 | $430.5K | $-1.7M |
| Q4 25 | 60.2% | — | ||
| Q3 25 | -22.9% | 0.7% | ||
| Q2 25 | 50.4% | 68.2% | ||
| Q1 25 | 55.2% | 73.0% | ||
| Q4 24 | 51.1% | 74.2% | ||
| Q3 24 | 17.4% | 83.0% | ||
| Q2 24 | 28.3% | 31.0% | ||
| Q1 24 | 38.1% | 13.6% |
| Q4 25 | -632.0% | — | ||
| Q3 25 | -531.4% | -953.5% | ||
| Q2 25 | -1590.0% | — | ||
| Q1 25 | -1168.4% | -6.5% | ||
| Q4 24 | -854.7% | -229.5% | ||
| Q3 24 | -1566.0% | -391.4% | ||
| Q2 24 | -3351.8% | — | ||
| Q1 24 | -1270.4% | -85.9% |
| Q4 25 | -474.2% | — | ||
| Q3 25 | -529.3% | -1169.1% | ||
| Q2 25 | -1717.7% | — | ||
| Q1 25 | -1147.4% | 189.0% | ||
| Q4 24 | -846.3% | -77.0% | ||
| Q3 24 | -1596.4% | -458.5% | ||
| Q2 24 | -3339.0% | — | ||
| Q1 24 | 407.4% | -107.3% |
| Q4 25 | $-8.26 | — | ||
| Q3 25 | $-0.66 | $-0.38 | ||
| Q2 25 | $-1.25 | — | ||
| Q1 25 | $-1.56 | $1.09 | ||
| Q4 24 | $-51.96 | $-11.32 | ||
| Q3 24 | $-2.92 | $-17.62 | ||
| Q2 24 | $-21.12 | — | ||
| Q1 24 | $1.83 | $-116.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.8M | — |
| Total DebtLower is stronger | $150.0K | — |
| Stockholders' EquityBook value | $3.5M | $12.0M |
| Total Assets | $5.4M | $16.6M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.8M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $3.5M | $2.5K | ||
| Q4 24 | $3.4M | $504.3K | ||
| Q3 24 | $5.0M | $44.1K | ||
| Q2 24 | $1.6M | $171.6K | ||
| Q1 24 | — | — |
| Q4 25 | $150.0K | — | ||
| Q3 25 | $150.0K | — | ||
| Q2 25 | $150.0K | — | ||
| Q1 25 | $150.0K | — | ||
| Q4 24 | $150.0K | — | ||
| Q3 24 | $150.0K | — | ||
| Q2 24 | $150.0K | — | ||
| Q1 24 | $150.0K | — |
| Q4 25 | $3.5M | — | ||
| Q3 25 | $4.4M | $12.0M | ||
| Q2 25 | $2.4M | $10.7M | ||
| Q1 25 | $4.1M | $29.1M | ||
| Q4 24 | $4.0M | $18.4M | ||
| Q3 24 | $6.0M | $6.3M | ||
| Q2 24 | $3.0M | $3.4M | ||
| Q1 24 | $7.2M | $3.1M |
| Q4 25 | $5.4M | — | ||
| Q3 25 | $6.7M | $16.6M | ||
| Q2 25 | $4.2M | $14.9M | ||
| Q1 25 | $6.0M | $30.4M | ||
| Q4 24 | $5.8M | $19.1M | ||
| Q3 24 | $7.4M | $7.1M | ||
| Q2 24 | $4.3M | $4.3M | ||
| Q1 24 | $8.4M | $4.2M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.03× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-1.8M |
| Free Cash FlowOCF − Capex | $-1.8M | $-2.4M |
| FCF MarginFCF / Revenue | -584.2% | -1318.2% |
| Capex IntensityCapex / Revenue | 26.3% | 353.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $-2.1M | $-1.8M | ||
| Q2 25 | $-1.5M | $-9.5M | ||
| Q1 25 | $-1.6M | $-4.2M | ||
| Q4 24 | $-1.6M | $-606.2K | ||
| Q3 24 | $-1.7M | $-976.3K | ||
| Q2 24 | $-1.2M | $-4.7M | ||
| Q1 24 | $-1.1M | $-1.1M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-2.1M | $-2.4M | ||
| Q2 25 | $-1.5M | $-9.5M | ||
| Q1 25 | $-1.6M | $-4.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-1.1M |
| Q4 25 | -584.2% | — | ||
| Q3 25 | -484.2% | -1318.2% | ||
| Q2 25 | -1483.6% | -822.4% | ||
| Q1 25 | -978.3% | -635.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1252.8% | — | ||
| Q2 24 | — | -1614.2% | ||
| Q1 24 | — | -67.1% |
| Q4 25 | 26.3% | — | ||
| Q3 25 | 2.3% | 353.3% | ||
| Q2 25 | 46.9% | 1.3% | ||
| Q1 25 | 1.6% | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.